Meredith serves as the primary subject matter expert within i2E and Plains Ventures in evaluating life sciences and biotech investment opportunities.  Prior to joining i2E and Plains Ventures, Meredith worked in the Office of Technology Commercialization at the University of Oklahoma.  In this role, she identified and evaluated life sciences technologies that were ready for a coordinated strategy of intellectual property protection and marketing to potential industry partners.

Meredith earned her PhD in neuroscience from the University of Kansas and completed post-doctoral fellowships at the Washington University School of Medicine in St. Louis and the Lynn Health Science Institute in Oklahoma City.  She has experience coordinating and managing clinical trials at the research site level across a myriad of conditions.  She is dedicated to using her professional perspectives from academia, clinical trials, and technology transfer to support innovative life sciences and biotech ventures.